Astrazeneca (AZN) EPS (Basic) (2009 - 2026)
Astrazeneca (AZN) posted quarterly EPS (Basic) of $1.62 for Q2 2026, down 48.87% year-over-year from $3.16 in Q2 2025, and down 18.66% quarter-over-quarter from $1.99 in Q1 2026.
Astrazeneca (AZN) EPS (Basic) (2009 - 2026) Analysis & Trends
Astrazeneca's EPS (Basic) history runs 18 years deep, the most recent figure standing at $1.62 for Q2 2026.
- In Q2 2026, EPS (Basic) fell 48.87% year-over-year to $1.62; the TTM figure through Jun 2026 stood at $7.05 (down 48.57% YoY), while the FY2025 annual figure was $6.6, down 27.33% from the prior year.
- EPS (Basic) for Q2 2026 stood at $1.62, down from $1.99 in the prior quarter.
- The five-year high for EPS (Basic) was $5.18 in Q1 2025, with the low at -$0.48 in Q2 2022.
- The 5-year median for EPS (Basic) is $2.26 (2022), against an average of $2.3.
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) tumbled 126.48% in 2022, then surged 588.39% in 2023.
- Astrazeneca's EPS (Basic) stood at $2.21 in 2022, then rose by 3.96% to $2.3 in 2023, then declined by 15.83% to $1.94 in 2024, then declined by 7.67% to $1.79 in 2025, then retreated by 9.55% to $1.62 in 2026.
- Business Quant data shows AZN's EPS (Basic) at $1.62 in Q2 2026, $1.99 in Q1 2026, and $1.79 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 2.30 |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 1.71 |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 1.62 |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 4.40 |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -0.04 |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 0.29 |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 0.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.62 |
| Mar 31, 2026 | 1.99 |
| Dec 31, 2025 | 1.79 |
| Sep 30, 2025 | 3.32 |
| Jun 30, 2025 | 3.16 |
| Mar 31, 2025 | 5.18 |
| Dec 31, 2024 | 1.94 |
| Sep 30, 2024 | 3.42 |
| Jun 30, 2024 | 2.49 |
| Mar 31, 2024 | 2.81 |
| Dec 31, 2023 | 2.30 |
| Sep 30, 2023 | 1.77 |
| Jun 30, 2023 | 2.35 |
| Mar 31, 2023 | 2.82 |
| Dec 31, 2022 | 2.21 |
| Sep 30, 2022 | 2.12 |
| Jun 30, 2022 | -0.48 |
| Mar 31, 2022 | 0.57 |
| Dec 31, 2021 | -1.05 |
| Sep 30, 2021 | -3.02 |